Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Demircan

Showing results (901-910 of 970) with videos related to

Pageof 97
Sort By:
Journal of Chemotherapy (Florence, Italy)|April 17, 2026
Acquired <i>CD74-ROS1</i> fusion-mediated osimertinib resistance successfully treated with osimertinib and crizotinib: a case reportAli Kaan Güren, Erkam Kocaaslan, Yeşim Ağyol, et al.
European Journal of Public Health|August 7, 2014
Factors affecting breast cancer treatment delay in Turkey: a study from Turkish Federation of Breast Diseases SocietiesVahit Ozmen, Sukru Boylu, Engin Ok, et al.
Annals of Saudi Medicine|June 7, 2026
Comparative overall survival in T4N0 and T2-3N1 non-metastatic colon cancer: a retrospective cohort studyFırat Akagunduz, Ali Kaan Güren, Erkam Kocaaslan, et al.
Oncology Letters|May 1, 2023
Prognostic significance of mucinous histology in left‑sided metastatic colorectal cancers with wild‑type RAS and evaluation of backbone chemotherapy regimensRukiye Arikan, Muhammed Mustafa Atci, Seval Ay, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 8, 2024
T-cell specific in vivo gene delivery with DART-AAVs targeted to CD8Muhammed Burak Demircan, Luca J Zinser, Alexander Michels, et al.
Cell Stem Cell|December 10, 2013
Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patientsGerald Schwank, Bon-Kyoung Koo, Valentina Sasselli, et al.
Tumori|September 4, 2020
Differences in PET/CT standardized uptake values involvement and survival compared to histologic subtypes of lung adenocarcinomaOzlem Ercelep, Ozkan Alan, Tugba A Telli, et al.
Indian Journal of Cancer|February 17, 2025
Prognostic value of psoas muscle index in metastatic renal cell carcinoma patients treated with anti-VEGF therapyRukiye Arıkan, Özlem Demircioğlu, Salih Özgüven, et al.
Annals of Nuclear Medicine|August 23, 2022
Role of baseline <sup>68</sup>Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatmentTugba Akin Telli, Salih Ozguven, Ozkan Alan, et al.
Revista Espanola De Medicina Nuclear E Imagen Molecular|May 16, 2022
Predictive value of <sup>18</sup>F-FDG PET/CT indices on extensive residual cancer burden in breast cancer patients treated with neoadjuvant chemotherapyTuğba Başoğlu, Salih Özgüven, Hülya Şahin Özkan, et al.
Pageof 97

Showing results (901-910 of 970) with videos related to

Sort By:
Pageof 97
Journal of Chemotherapy (Florence, Italy)|April 17, 2026
Acquired <i>CD74-ROS1</i> fusion-mediated osimertinib resistance successfully treated with osimertinib and crizotinib: a case reportAli Kaan Güren, Erkam Kocaaslan, Yeşim Ağyol, et al.
European Journal of Public Health|August 7, 2014
Factors affecting breast cancer treatment delay in Turkey: a study from Turkish Federation of Breast Diseases SocietiesVahit Ozmen, Sukru Boylu, Engin Ok, et al.
Annals of Saudi Medicine|June 7, 2026
Comparative overall survival in T4N0 and T2-3N1 non-metastatic colon cancer: a retrospective cohort studyFırat Akagunduz, Ali Kaan Güren, Erkam Kocaaslan, et al.
Oncology Letters|May 1, 2023
Prognostic significance of mucinous histology in left‑sided metastatic colorectal cancers with wild‑type RAS and evaluation of backbone chemotherapy regimensRukiye Arikan, Muhammed Mustafa Atci, Seval Ay, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 8, 2024
T-cell specific in vivo gene delivery with DART-AAVs targeted to CD8Muhammed Burak Demircan, Luca J Zinser, Alexander Michels, et al.
Cell Stem Cell|December 10, 2013
Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patientsGerald Schwank, Bon-Kyoung Koo, Valentina Sasselli, et al.
Tumori|September 4, 2020
Differences in PET/CT standardized uptake values involvement and survival compared to histologic subtypes of lung adenocarcinomaOzlem Ercelep, Ozkan Alan, Tugba A Telli, et al.
Indian Journal of Cancer|February 17, 2025
Prognostic value of psoas muscle index in metastatic renal cell carcinoma patients treated with anti-VEGF therapyRukiye Arıkan, Özlem Demircioğlu, Salih Özgüven, et al.
Annals of Nuclear Medicine|August 23, 2022
Role of baseline <sup>68</sup>Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatmentTugba Akin Telli, Salih Ozguven, Ozkan Alan, et al.
Revista Espanola De Medicina Nuclear E Imagen Molecular|May 16, 2022
Predictive value of <sup>18</sup>F-FDG PET/CT indices on extensive residual cancer burden in breast cancer patients treated with neoadjuvant chemotherapyTuğba Başoğlu, Salih Özgüven, Hülya Şahin Özkan, et al.
Pageof 97